http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108250215-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-6561 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6561 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5365 |
filingDate | 2016-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2022-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2022-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-108250215-B |
titleOfInvention | Novel anti-HIV medicine, preparation method and application thereof |
abstract | The invention relates to a novel anti-HIV drug and clinical application thereof, wherein the novel anti-HIV drug has a structure shown in a formula (I). The invention also provides a compound shown in the formula (I) or a hydrate, a solvate, a co-crystal, a pharmaceutically acceptable salt and a preparation method thereof. The pharmaceutical composition of the compound is used in medicine, in particular to the treatment of acquired immunodeficiency syndrome. (Ⅰ)。 |
priorityDate | 2016-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 84.